Compliance with drug therapy - New answers to an old question

Nephrology Dialysis Transplantation

Volumn 16, Issue 7, 2001, Pages 1317-1321

  Düsing, Rainer ^a   Lottermoser, Katja ^a   Mengden, Thomas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Compliance; Drug therapy

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CONTRACEPTIVE AGENT; DIGOXIN; GEMFIBROZIL; PHENOBARBITAL; PLACEBO;

ARTICLE; AWARENESS; CLINICAL PRACTICE; COMPUTER; DEVICE; DOCTOR PATIENT RELATION; DRUG DOSE; DRUG MONITORING; DRUG PACKAGING; DRUG RESEARCH; DRUG SENSITIVITY; DRUG THERAPY; ECONOMIC ASPECT; ELECTRONICS; FOLLOW UP; HEALTH CARE; HUMAN; LEISURE; MEASUREMENT; PATIENT COMPLIANCE; PHYSICIAN; PRIORITY JOURNAL; STANDARD; TECHNIQUE;

EID: 0034940781     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.7.1317     Document Type: Article

References (25)

1. Introduction
2. Compliance to pilocarpine therapy
3. The electronic medication event monitor. Lessons for pharmacotherapy
4. Measuring compliance in clinical trials and ambulatory care
5. Role of patient compliance in clinical pharmacokinetics: Review of recent research
6. The place of microelectronic systems in measuring compliance
7. A critical review of the determinants of patient compliance with therapeutic regimens
8. The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals
9. Changes in antihypertensive therapy-the role of adverse effects and compliance
10. Pharmacoeconomic impact of variable compliance
11. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
12. Compliance with medication in the Helsinki Heart Study
13. Noncompliance in organ transplant recipients: A literature review
14. Renal transplant patient compliance with free immunosuppressive medications
15. Medication compliance following renal transplantation
16. Current thinking on chronic renal allograft rejection: Issues, concerns, and recommendation from a 1997 roundtable discussion
17. Methodological issues in transplant compliance research
18. Adherence: A necessity for successful HIV combination therapy
19. Adherence to HIV combination therapy
20. Attaining higher goals in HIV treatment: The central importance of adherence
21. Impact of unrecognized dosing errors on the cost and effectiveness of pharmaceuticals
22. Drug compliance decreases between clinic visits. The effect of white-coat compliance on 24-h ambulatory blood pressure monitoring
23. Compliance declines between clinic visits
24. Issues in patient compliance
25. Prescription medicine compliance: A review of the baseline of knowledge-a report of the National Council on Patient Information and Education